The X-StopPK® device is designed to treat the symptoms of lumbar spinal stenosis (LSS), a sometimes painful condition caused by narrowing of the spinal canal. The X-StopPK® device is designed to keep the space between your spinous processes open, so that when you stand upright, the nerves in your back will not be pinched or cause pain.
By enlarging the space between the bones in your back, the X-StopPK® device reduces pressure on the spinal nerves, thereby alleviating the symptoms of lumbar spinal stenosis, including:
- Leg pain, cramping
- Numbness or tingling in the lower back, buttocks and legs
The X-StopPK® device has undergone clinical studies and is the only device approved by the FDA to treat the symptoms of LSS. The X-StopPK® IPD® procedure offers superior relief of LSS symptoms and overall treatment success when compared with non-surgical treatment.
The X-StopPK® device is designed to remain safely and permanently in place without attaching screws or hardware to the bone or ligaments in your back. In addition, the bone and tissue removal typically associated with traditional back surgery is not necessary with this device, so the natural anatomy of the spine is preserved.
Benefits:
Depending upon your anatomy and specific medical conditions, the X-StopPK® IPD® Procedure offers several benefits including:
- Fast pain relief
- The option of local or general anaesthesia
- The possibility of having an outpatient procedure (cost-effective)
- Short recovery time and early return to normal activities
- All other surgical treatment options remain open
- No structural bone and tissue is removed
- The anatomy of the spine is preserved
About Interspinous Devices
Interspinous spacers sometimes also called as Interspinous process decompression systems, are the devices implanted between vertebral spinous processes. These spacers are made up of a very strong but lightweight metal (titanium) which is biocompatible in the human body. These devices are imbedded in body to confine painful motion else enabling normal motion and to treat lumbar spinal stenosis, discogenic low-back pain, facet syndrome, disc herniations, and non-traumatic instability. Lumbar spinal stenosis is a thinning of the spinal canal in the lower back which causes compression on nerves and it is developed gradually with age. Radiology tests are used to confirm a diagnosis of moderate degenerative lumbar spinal stenosis. People with lumbar spinal stenosis experience pain but may also have weakness in their leg, lower back and buttocks, numbness, tingling.
The Interspinous spacer are implanted between those vertebrae in such a way that it prevents the patient from bending too far backward which causes pain by surgical procedure. The procedure is very small and sometimes patient can go home within a day.The increasing prevalence of spinal stenosis due to aging, arthritis, heredity and increased demand of surgical procedures that improved lifestyle and comfort will drive the Interspinous spacer market. The adoption of spacers are increasing due to low complication rate as compared to decompression and spinal fusion. The Interspinous spacers are widely used in geriatric population as per Medicare data due to old age patient are not comfortable with surgery due to their health conditions. Source:Transparency Market Research (TMR)
About Medtronic
Medtronic, Inc. (NYSE: MDT), based in suburban Minneapolis, Minnesota, is theworld’s largest medical technology company and is a Fortune 500 company.Medtronic was founded in 1949 in a garage in northeast Minneapolis by Earl Bakken and his brother-in-law Palmer Hermundslie as a medical equipment repair shop. They originally wanted to sell basketball pumps due to a shortage in the Midwest in the 20th century. Bakken began as a graduate student in electrical engineering at the University of Minnesota before he gave up his studies to focus on Medtronic.Through their repair business, Bakken came to know C. Walton Lillehei, a pioneer in the field of heart surgery then at the University of Minnesota Medical School. Lillehei was frustrated with the pacemakers of the day, which were quite large, applied electrical current externally (requiring higher voltages), and had to be plugged in to a wall outlet to operate. The deficiencies of such pacemakers were made painfully obvious following a power outage over Halloween in 1957 which affected large sections of Minnesota and western Wisconsin.As a direct result of this blackout, a pediatric patient of Dr. Lillehei who was pacemaker-dependent died. The next day, Lillehei spoke with Bakken about developing some form of battery-powered pacemaker. Stemming from this need, Bakken modified a design for a transistorized metronome to create the first battery-powered external artificial pacemaker.